Michael Wayne Kalb

Chief Financial Officer at Catalyst Pharmaceuticals · 5 reported transactions in 1 company · latest report Jul 15, 2026

Their trades


Catalyst PharmaceuticalsCPRX	Returned to company $430.4K · 13,665 shares	Jul 15, 2026
Catalyst PharmaceuticalsCPRX	Shares withheld for tax — · 2,080 shares	Jan 5, 2026
Catalyst PharmaceuticalsCPRX	Exercised options — · 7,139 shares	Jan 5, 2026
Catalyst PharmaceuticalsCPRX	Shares withheld for tax — · 2,485 shares	Nov 21, 2025
Catalyst PharmaceuticalsCPRX	Exercised options — · 6,894 shares	Nov 21, 2025

Jul 15, 2026 · CPRX

$430.4K

Jan 5, 2026 · CPRX

2,080

Jan 5, 2026 · CPRX

7,139

Nov 21, 2025 · CPRX

2,485

Nov 21, 2025 · CPRX

6,894

5 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Chief Financial Officer at Catalyst Pharmaceuticals · 5 reported transactions in 1 company · latest report Jul 15, 2026


Catalyst PharmaceuticalsCPRX	Returned to company $430.4K · 13,665 shares	Jul 15, 2026
Catalyst PharmaceuticalsCPRX	Shares withheld for tax — · 2,080 shares	Jan 5, 2026
Catalyst PharmaceuticalsCPRX	Exercised options — · 7,139 shares	Jan 5, 2026
Catalyst PharmaceuticalsCPRX	Shares withheld for tax — · 2,485 shares	Nov 21, 2025
Catalyst PharmaceuticalsCPRX	Exercised options — · 6,894 shares	Nov 21, 2025